NHT
NVO

New Hampshire Trust’s Novo Nordisk NVO Stock Holding History

New Hampshire Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,400
Closed -$206K – 177
2024
Q4 		$206K Sell
2,400
-130
-5% -$14.1K 0.04% 173
2024
Q3 		$301K Buy
2,530
+130
+5% +$17.3K 0.06% 155
2024
Q2 		$343K Hold
2,400
– – 0.08% 138
2024
Q1 		$308K Hold
2,400
– – 0.07% 142
2023
Q4 		$248K Hold
2,400
– – 0.06% 156
2023
Q3 		$218K Buy
+2,400
New +$211K 0.06% 157
2023
Q2 		– Sell
-2,400
Closed -$191K – 282
2023
Q1 		$191K Hold
2,400
– – 0.05% 168
2022
Q4 		$162K Buy
+2,400
New +$141K 0.04% 181

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

New Hampshire Trust's NVO Position: Q1 2025 in Review

New Hampshire Trust sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,400 shares — an estimated $206K sold.

New Hampshire Trust first reported a position in NVO in Q4 2022 and held it in 8 quarters. The position peaked at $343K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • New Hampshire Trust reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • New Hampshire Trust sold 2,400 Novo Nordisk shares in Q1 2025, an estimated $206K.
  • New Hampshire Trust first reported a position in Novo Nordisk in Q4 2022 and held it in 8 quarters.
  • New Hampshire Trust's Novo Nordisk position peaked at $343K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on New Hampshire Trust's 13F filing for Q1 2025, filed 8 Apr 2025.